Pentoxifylline NEW
| Price | $40 |
| Package | 500mg |
| Supply Ability: | 10g |
| Update Time: | 2026-07-27 |
Product Details
| Product Name: Pentoxifylline | CAS No.: 6493-05-6 |
| Purity: 99.96% | Supply Ability: 10g |
| Release date: 2026/07/27 |
Product Introduction
Bioactivity
| Name | Pentoxifylline |
| Description | Pentoxifylline (PTX) modulates immunologic activity by stimulating cytokine production. Pentoxifylline is a methylxanthine derivative that inhibits phosphodiesterase and affects blood rheology. It also inhibits platelet aggregation and improves blood flow by increasing erythrocyte and leukocyte flexibility. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O : 50.8 mg/mL (182.53 mM), Sonication is recommended. 10% DMSO+90% Saline : 4.9 mg/mL (17.61 mM), Solution. DMSO : 49 mg/mL (176.06 mM), Sonication is recommended. |
| Keywords | venous | vasculopathies | vasculitides | ulcers | purpuric | pigmented | Phosphodiesterase (PDE) | phosphodiesterase | peripheral vascular | Pentoxifylline | PDE | methyl-xanthine | leprosy | leg | intermittent | Inhibitor | inhibit | immunomodulator | Human immunodeficiency virus | HIVProtease | HIV Protease | HIV | hemorrheologic | hemorheological | diseases | dermatoses | dermatological | claudication | BL191 | BL 191 | Autophagy | anti-hypercholesterolemic | AdenosineReceptor | Adenosine Receptor | A2 |
| Inhibitors Related | Stavudine | Aceglutamide | Hemin | Emtricitabine | D(+)-Raffinose pentahydrate | Guanidine hydrochloride | Hydroxychloroquine | Lamivudine | Paeonol | Naringin | Alginic acid | Dextran sulfate sodium salt (MW 5000) |
| Related Compound Libraries | Anti-Neurodegenerative Disease Compound Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Anti-Viral Compound Library | Inhibitor Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Anti-Aging Compound Library | Bitter Compound library | GPCR Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
-
-
CAS:1185995-73-6
-
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-08-10 | ||
| $40.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-07-27 | |
| $40.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-07-27 | |
| $1.00 |
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2020-05-12 | |
| $7.00 |
VIP9Y
|
Career Henan Chemical Co
|
2019-07-06 | |
| $40.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-05-02 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, Massachusetts, USA
INQUIRY